Transpire Bio to Participate in Upcoming Healthcare Investor Conferences During September
Transpire Bio to Participate in Upcoming Healthcare Investor Conferences During September SUNRISE, Fla., Sep. 2, 2026 (PR NEWSWIRE) — Transpire Bio, a U.S.-based clinical-stage, biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that members of its executive leadership team will participate in two leading healthcare investor conferences during September 2026: […]